News - Sanofi

Filter

Current filters:

Sanofi

Popular Filters

301 to 304 of 304 results

Shire says Fabry and Gaucher disease studies continue to support patient switches to Replagal and Vpriv

01-09-2011

Ireland-headquartered specialty drug firm Shire (LSE: SHP) reported positive data from several studies…

CerezymeFabrazymeGenzymePharmaceuticalRare diseasesReplagalResearchSanofiShireVpriv

AstraZeneca’s Brilinta shows mortality benefit over gold-standard Plavix

30-08-2011

There was good news for Anglo-Swedish drug major AstraZeneca (LSE: AZN) yesterday, when the firm revealed…

AstraZenecaBrilintaCardio-vascularPharmaceuticalPlavixResearchSanofi

301 to 304 of 304 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top